What the experts didn't see coming during the pandemic; biotech trends to watch for in 2021

Over the past three years, the novel coronavirus and the world's response have continuously deviated from expert forecasts. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Three years on, the pandemic — and our response — have been jolting. Here's what even the experts didn't see coming By Helen Branswell Kevin Frayer/Getty Images Despite all the planning for a global pandemic, Covid-19 has not played out as expected. In short, we have a lot of learning left to do. Read More STAT+: Get ready for 'the electric vehicles of biopharma': Three biotech trends to watch in 2023 By Damian Garde Christine Kao/STAT Looking ahead to a promising Alzheimer's treatment, creative deal-making techniques, and a new generation of metabolic drugs. Read More Sponsored Insight by STAT+ Searching for the perfect gift? Get 3 months of STAT+ for $30. A STAT+ subscription gives you unlimited access to in-depth investigative journalism, groundbreaking analysis, subscriber-only newsletters, and industry event discounts. With a premium membership, you’ll get your life sciences news direct from the source. For a limited time only, get three months of STAT+ for just $30. Subscribe now. Opinion: To effectively combat diabetes, policymakers must treat obesity like other diseases By Robert Gabbay Adobe People with obesity shouldn't have to wait until they develop diabetes or other illness before Medicare covers obesity medication. Read More Tuesday, December 27, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser